These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 18028587)
1. Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study. Li H; Ma C; Wang G; Zhu X; Peng M; Gu N Curr Med Res Opin; 2008 Jan; 24(1):1-10. PubMed ID: 18028587 [TBL] [Abstract][Full Text] [Related]
2. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania. Sussman N; Mullen J; Paulsson B; Vågerö M J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736 [TBL] [Abstract][Full Text] [Related]
3. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Vieta E; Mullen J; Brecher M; Paulsson B; Jones M Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892 [TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Bowden CL; Grunze H; Mullen J; Brecher M; Paulsson B; Jones M; Vågerö M; Svensson K J Clin Psychiatry; 2005 Jan; 66(1):111-21. PubMed ID: 15669897 [TBL] [Abstract][Full Text] [Related]
5. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania. Ketter TA; Jones M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S45-53. PubMed ID: 17383011 [TBL] [Abstract][Full Text] [Related]
6. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial. Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797 [TBL] [Abstract][Full Text] [Related]
7. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms. McIntyre RS; Konarski JZ; Jones M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773 [TBL] [Abstract][Full Text] [Related]
8. Quetiapine in the treatment of acute mania: target dose for efficacious treatment. Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403 [TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M; J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369 [TBL] [Abstract][Full Text] [Related]
10. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine. Buckley PF; Paulsson B; Brecher M J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537 [TBL] [Abstract][Full Text] [Related]
11. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH; J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043 [TBL] [Abstract][Full Text] [Related]
12. A Randomized, Double-Blind, Controlled Trial of Lithium Versus Quetiapine for the Treatment of Acute Mania in Youth with Early Course Bipolar Disorder. Patino LR; Klein CC; Strawn JR; Blom TJ; Tallman MJ; Adler CM; Welge JA; DelBello MP J Child Adolesc Psychopharmacol; 2021 Sep; 31(7):485-493. PubMed ID: 34520250 [No Abstract] [Full Text] [Related]
13. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder. Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR; J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817 [TBL] [Abstract][Full Text] [Related]
15. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644 [TBL] [Abstract][Full Text] [Related]
16. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study. Bauer M; Pretorius HW; Constant EL; Earley WR; Szamosi J; Brecher M J Clin Psychiatry; 2009 Apr; 70(4):540-9. PubMed ID: 19358791 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial. Pathak S; Findling RL; Earley WR; Acevedo LD; Stankowski J; Delbello MP J Clin Psychiatry; 2013 Jan; 74(1):e100-9. PubMed ID: 23419231 [TBL] [Abstract][Full Text] [Related]
18. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Sachs G; Chengappa KN; Suppes T; Mullen JA; Brecher M; Devine NA; Sweitzer DE Bipolar Disord; 2004 Jun; 6(3):213-23. PubMed ID: 15117400 [TBL] [Abstract][Full Text] [Related]
19. Quetiapine: a review of its use in the management of bipolar depression. Sanford M; Keating GM CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923 [TBL] [Abstract][Full Text] [Related]
20. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study. El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]